Revolutionary Microbiome Research, Discovery and Testing

Intus Bio’s patented 16S-ITS-23S amplicon powers our Titan-1 platform, generating enough information to differentiate strains without having to sequence the whole genome.

Our unique approach considers the multiple copies of the 16S-ITS-23S region individually, creating a bacterial strain’s unique composite “fingerprint.” These fingerprints enable strain-level identification and tracking for known and novel strains.

Proprietary software and analysis tools then track the ”fingerprints” to find a particular strain, discover important bacteria across whole populations, or produce individual sample reports on a whole sample basis.

Our Titan-1 Platform Produces Strain Level Data at Scale

Unlike Intus Bio, almost all technologies available today produce only genus and species level results – not strains.  Strains are the fundamental unit of the microbiome. Identifying and tracking strains is the key to actionable results. 

For example:

• One strain of Lactobacillus can be a key biomarker for drug response or disease diagnosis, while another could play no role
• One strain of E. coli can be a commensal, another a lethal pathogen

Intus Bio’s Titan-1 platform is unique in that it can immediately identify and track strains – whether they have been previously sequenced or not. Other approaches to differentiating novel strains are costly, data intensive and time consuming.

Intus Bio’s platform produces results with speed, accuracy and scalability, and is unique in its ability to produce strain level information for known and unknown strains.